Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate ...

Cornell researchers have identified the signaling mechanism that triggers steroid-induced glaucoma by creating a 3D “eye-on-a ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents.

This chip system has potential applications beyond viral infections, and could be used to enhance personalized medicine by enabling the use of patient-specific iPSCs to study other conditions as well.

GENEVA — In a move to strengthen its system-on-chip campaign, STMicroelectronics today announced it will spend $17.1 million to acquire privately-held Portland Group Inc., a supplier of compilers and ...

Linda Griffith, bioengineer and director of MIT's Center for Gynepathology Research, is working to grow human tissue on bits ...